|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.25 USD | -3.20% |
|
-12.76% | +81.25% |
| 15/03 | XBiotech Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| 04/01 | XBiotech Inc. to Begin Constructing New R&D Facility on Its 48-Acre Campus | CI |
XBiotech Inc. reported earnings results for the full year ended December 31, 2021. For the full year, the company reported revenue was USD 18.39 million compared to USD 44 million a year ago. Net loss was USD 17.41 million compared to USD 11.22 million a year ago.
Basic loss per share from continuing operations was USD 0.58 compared to USD 0.36 a year ago. Diluted loss per share from continuing operations was USD 0.58 compared to USD 0.36 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| +81.25% | 221M | |
| +11.91% | 118B | |
| +11.60% | 106B | |
| -4.68% | 24.28B | |
| -0.82% | 21.96B | |
| -10.12% | 18.16B | |
| -42.12% | 16.37B | |
| -17.47% | 15.56B | |
| +2.77% | 13.63B | |
| +34.58% | 12.27B |
XBIOTECH INC. 
